摘要
用康莱特注射液静脉滴注２００ｍｌ，每日一次，４０天为一疗程，经对２４２例原发性肺癌的随机分组对照治疗观察，结果表明康莱特注射液在缓解癌灶，对证候、体重、生存质量、免疫功能和血象方面均有良好的改善作用，肿瘤缓解率（ＣＲ＋ＰＲ）为２０．６１％，对照组肿瘤缓解率为２５．２３％，经统计学分析，两者之间无显著性差异（Ｐ＞０．０５）。提示康莱特注射液对肺癌病人气阴两虚、脾虚痰湿证有较好的治疗效果，对于不能耐受化疗者，尤为适宜。
cases of Primary lung cancer were treated by Kanglaite injection (200 ml,iv gtt, qd for 40d) , and a control group treated with chemotherapy (MAP) was cornpared.The results showed that Kanglaite injection can reduce the diseased focus and symptonms, in-crease the body weight, and improve the life quality, the immundogic function and the bloodpicture. The tumour remission rate (CR +PR) of the treatment group and the control groupwere 20. 61 % and 25. 23 % respectively (P<0. 05) . It is concluded that Kanglaite injection iseffective for lung cancer with dificiency of both qi and yin as well as hypofunction of the spleenand retention of wetnessphlegm , especially those with poor tolerance to chemotherapy.
出处
《中药新药与临床药理》
CAS
CSCD
1995年第4期17-22,共6页
Traditional Chinese Drug Research and Clinical Pharmacology
关键词
康莱特注射液
肺肿瘤
中医药疗法
Kanglaite injection/therapeutic use
Lung neoplasms/therapy, TCM
